Cyclosporine News and Research

RSS
Cyclosporine is a drug used to help reduce the risk of rejection of organ and bone marrow transplants by the body. It is also used in clinical trials to make cancer cells more sensitive to anticancer drugs.
Advance team of molecules produced by primary tumor is responsible for lung cancer metastasis

Advance team of molecules produced by primary tumor is responsible for lung cancer metastasis

FDA approves Astellas' ASTAGRAF XL for prophylaxis of organ rejection in kidney transplant patients

FDA approves Astellas' ASTAGRAF XL for prophylaxis of organ rejection in kidney transplant patients

Researchers provide new revelations about intricate pathways involved in turning on T cells

Researchers provide new revelations about intricate pathways involved in turning on T cells

Merck's LIPTRUZET tablets get FDA approval for treatment of elevated LDL cholesterol

Merck's LIPTRUZET tablets get FDA approval for treatment of elevated LDL cholesterol

Arthritis drug reduces dry eye disease

Arthritis drug reduces dry eye disease

FDA accepts Merck's NDA for NOXAFIL tablets

FDA accepts Merck's NDA for NOXAFIL tablets

Abstracts on Bristol-Myers Squibb's research in liver disease accepted for presentation

Abstracts on Bristol-Myers Squibb's research in liver disease accepted for presentation

Study: Drug normally used to treat severe bronchial asthma beneficial for chronic urticaria sufferers

Study: Drug normally used to treat severe bronchial asthma beneficial for chronic urticaria sufferers

Regeneron, Sanofi announce pooled data from Phase 1b trials with dupilumab for atopic dermatitis

Regeneron, Sanofi announce pooled data from Phase 1b trials with dupilumab for atopic dermatitis

Omalizumab fast, safe and well-tolerated in teens and adults with chronic spontaneous urticaria

Omalizumab fast, safe and well-tolerated in teens and adults with chronic spontaneous urticaria

FDA approves Novartis’ Zortress to prevent organ rejection after liver transplantation in adults

FDA approves Novartis’ Zortress to prevent organ rejection after liver transplantation in adults

Delaware District Court rules in favor of Pfizer in RAPAMUNE patent case

Delaware District Court rules in favor of Pfizer in RAPAMUNE patent case

Thermo Scientific QMS Everolimus Assay Kit receives CE Mark for liver transplant application

Thermo Scientific QMS Everolimus Assay Kit receives CE Mark for liver transplant application

FDA approves Novartis Signifor injection for treatment of Cushing's disease

FDA approves Novartis Signifor injection for treatment of Cushing's disease

NeuroVive announce results from CicloMulsion Phase I trial on cardiac reperfusion injury

NeuroVive announce results from CicloMulsion Phase I trial on cardiac reperfusion injury

University of Cincinnati to lead Belatacept Early Steroid withdrawal Trial

University of Cincinnati to lead Belatacept Early Steroid withdrawal Trial

Specific combination of two pharmaceutical substances show promise against multiple sclerosis

Specific combination of two pharmaceutical substances show promise against multiple sclerosis

Myasthenia gravis therapies: an interview with Professor Daniel Drachman

Myasthenia gravis therapies: an interview with Professor Daniel Drachman

Patients with focal segmental glomerulosclerosis tend to have high suPAR levels

Patients with focal segmental glomerulosclerosis tend to have high suPAR levels

FDA approves Pfizer’s XELJANZ to treat rheumatoid arthritis

FDA approves Pfizer’s XELJANZ to treat rheumatoid arthritis